Revised SPC: Provera (medroxyprogesterone acetate) 10 mg Tablets

SPC updated to contraindicate use if there is a known or suspected pregnancy, to advise that conception may be delayed following discontinuation, and that lactation data are limited, but treatment should not be given sooner than 6 weeks post-partum.


electronic Medicines compendium